Atlas Trials

Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

Clinical trial NCT00528398 · COMPLETED

Trial details

NCT number
NCT00528398
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
1994-09-01
Primary completion
2015-12-01
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.